Reltecimod TFA

Reltecimod TFA
Item number Size Datasheet Manual SDS Delivery time Quantity Price
TGM-T78107-5mg 5 mg - - -

7 - 10 business days*

31.00€
TGM-T78107-10mg 10 mg - - -

7 - 10 business days*

49.00€
TGM-T78107-25mg 25 mg - - -

7 - 10 business days*

100.00€
TGM-T78107-50mg 50 mg - - -

7 - 10 business days*

161.00€
TGM-T78107-100mg 100 mg - - -

7 - 10 business days*

240.00€
TGM-T78107-200mg 200 mg - - -

7 - 10 business days*

357.00€
 
Description: Reltecimod TFA (AB-103 TFA) is a CD28 (T-lymphocyte receptor) mimetic that acts as a... more
Product information "Reltecimod TFA"
Description: Reltecimod TFA (AB-103 TFA) is a CD28 (T-lymphocyte receptor) mimetic that acts as a CD28 antagonist, inhibiting the stimulation of t-cells by a range of bacterial pathogens thereby attenuating acute inflammation for the treatment of necrotizing soft tissue infections (NSTI). Target: Immunology/Inflammation related, Antibacterial. Smiles: [H]N[C@@H](C)C(N[C@H](C(N1CCC[C@H]1C(N[C@@H](CCSC)C(N[C@H](C(N[C@H](C(N[C@@H](C)C(N[C@@H](CC2=CC=C(C=C2)O)C(N[C@@H](CC(O)=O)C(N[C@@H](C)C(O)=O)=O)=O)=O)=O)C(C)C)=O)CC(C)C)=O)=O)=O)CO)=O.OC(C(F)(F)F)=O. References: Edgar, R., Tarrio, M.L., Maislin, G. et al. Treatment with One Dose of Reltecimod is Superior to Two Doses in Mouse Models of Lethal Infection. Int J Pept Res Ther 26, 1669-1683 (2020).
Keywords: Reltecimod TFA , AB103 TFA , AB-103 TFA
Supplier: TargetMol
Supplier-Nr: T78107

Properties

Conjugate: No
MW: 1151.21 D
Formula: C48H73F3N10O17S

Database Information

Handling & Safety

Storage: +4°C
Shipping: +20°C (International: +4°C)
Caution
Our products are for laboratory research use only: Not for administration to humans!
Information about the product reference will follow. more
You will get a certificate here
or to request a certificate of analysis.
Read, write and discuss reviews... more
Customer review for "Reltecimod TFA"
Write a review
or to review a product.
Viewed